đź“Ł ActiGraph Acquires Biofourmis Life Science Business

Learn More

THERAPEUTIC EXPERTISE

Solutions for Oncology Research

Digital health technologies empower the much-needed transformation of oncology drug development, enabling more effective trial designs that focus on the patient. Remote data collection reduces patient burden and improves the speed, cost-effectiveness, and the patient-centric nature of oncology trials, including immunotherapy treatments such as CAR-T cell therapy and trials investigating associated conditions such as cancer pain and cancer cachexia.

Schedule a Meeting Read Case Studies

Selected Digital Endpoints in Oncology

Physical Activity
  • Moderate to Vigorous Physical Activity (MVPA)
  • Non-Sedentary Time
  • Daily Total Activity Counts
  • Walking (step count, peak cadence, walking speed)
Sleep
  • Total Sleep Time
  • Wake After Sleep Onset (WASO)
  • Sleep Onset Latency
  • Sleep Efficiency
Vital Signs
  • Heart Rate (HR)
  • Respiratory Rate (RR)
  • Atrial fibrillation (Afib)
  • Oxygen Saturation (SpO2)
  • Blood Pressure
  • Skin Temperature
Cardinal Symptoms
  • Cough Frequency
  • Cough Bouts

To learn more about opportunities with digital health technologies in oncology clinical trials, download our full Digital Endpoint Guide: Oncology.

Functional Assessments

Functional Assessments

Physical functioning and sleep are meaningful to patients’ quality of life and often correlate with improved outcomes. However, traditional assessments of these meaningful aspects of health are episodic and subjective, limiting the insights they can provide.

Demonstrate meaningful patient-centric benefits and make informed, data-based decisions with continuous, quantitative, digital measures of physical activity, mobility, and sleep behavior collected with our state-of-the-art wearable digital health technology solution.

Key Features and Benefits:

  • FDA cleared, medical-grade wearables
  • Passive, remote data collection and transfer
  • Participant adherence monitoring
  • Simple technology deployments & end-to-end operational support
Read the Case Study

Immunotherapy-Related Adverse Events

Immunotherapies including CAR-T cell therapy, Bi-specific T-cell engager (BiTE) therapy, and immune checkpoint inhibitors are promising advancements in cancer treatment, but risk of serious adverse events such as cytokine release syndrome (CRS), neurotoxicity, and sepsis lead to prolonged hospital stays that can increase patient burden and trial costs.

Overcome these barriers with our remote patient monitoring platform and AI-powered risk monitoring. Continuous, remote monitoring of patient vital signs can reduce or eliminate prolonged hospitalization to reduce burden and cost while still prioritizing patient safety.

Key Features and Benefits

  • Algorithm-enabled decision support
  • AI-Powered CRS monitoring
  • Integrated remote patient monitoring platform
  • Real-time data access
gfx1@2x
13
trials
2,774
participants
24
countries
495
sites

Discuss your trial needs with one of ActiGraph’s digital health technology experts.

Schedule a Call